Deerfield, IL, United States
Deerfield, IL, United States

Baxter International Inc. is an American health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions. Wikipedia.


Time filter

Source Type

Patent
Baxter International and Baxter Healthcare Sa | Date: 2016-11-16

A dialysis system includes a fluid line fluidly communicating with a fluid source, a peritoneal dialysis unit configured to be placed in fluid communication with the fluid line, the peritoneal dialysis unit including a first user interface and a first control unit, the first user interface configured to receive first user inputs related to a peritoneal dialysis treatment, the first control unit configured to operate the peritoneal dialysis unit in accordance with the first user inputs to perform the peritoneal dialysis treatment, and a blood treatment unit configured to be placed in fluid communication with the fluid line, the blood treatment unit including a second user interface and a second control unit, the second user interface configured to receive second user inputs related to a blood treatment, the second control unit configured to operate the blood treatment unit in accordance with the second user inputs to perform the blood treatment.


Patent
Baxter International and Baxter Healthcare Sa | Date: 2016-11-18

A dialysis system includes a dialysis machine configured to control fluid loss or ultrafiltration (UF) volume over a treatment; a graphical user interface (GUI) that allows selection of a prescription entry for the treatment; and a processor operating with the GUI, the processor programmed to (i) receive a plurality of prescription entries via a local or wide area mode of data communication, each prescription entry including at least one prescribed parameter for operating the dialysis machine to control the fluid loss or UF volume, and (ii) enable an operator to choose between the prescription entries provided at the GUI, and select one of the prescription entries for the treatment.


Patent
Baxter International and Baxter Healthcare Sa | Date: 2016-12-01

The present invention provides a hemostatic composite sponge comprising a porous matrix of a biomaterial and a bioadhesive material stably associated with said sponge and present in an organized pattern on said sponge.


Patent
Baxter International and Baxter Healthcare SA | Date: 2016-08-12

Methods, systems, and apparatuses integrating medical device data are disclosed. In an example embodiment, a vital sign monitor apparatus includes a renal failure therapy interface configured to receive a renal failure therapy parameter from a renal failure therapy machine performing a renal therapy treatment on a patient and an infusion pump interface configured to receive an infusion parameter from an infusion pump performing an infusion treatment for the same patient. The apparatus also includes a vital sign monitor engine configured to display, within a combination user interface of a vital sign monitor, the renal failure therapy parameter within a renal failure therapy timeline, and the infusion parameter within an infusion timeline that is aligned with the renal failure therapy timeline.


Patent
Baxter International and Baxter Healthcare SA | Date: 2016-10-12

A hemodialysis system comprising: a source of priming fluid; an extracorporeal circuit including an arterial line, a venous line, and a drip chamber; a level sensor operable with the drip chamber; a reversible blood pump operable with the extracorporeal circuit; a connection between the arterial and the venous line; and a priming sequence in which priming fluid from the source is pumped in a reverse pump direction through the extracorporeal circuit and reversibly in a normal pump direction through the extracorporeal circuit, wherein an output from the level sensor is used to determine when to stop pumping in at least one of the directions.


Patent
Baxter International | Date: 2016-11-29

An infusion pump operable with a syringe having a syringe barrel and a syringe plunger includes a housing having a compartment to receive the syringe and defining a wall, and a syringe clamp moveable towards and away from the wall, the syringe clamp contacting the syringe barrel; a drive mechanism supported and structured and arranged to contact and end of the syringe plunger so as to be able to move the syringe plunger within the syringe barrel; a syringe barrel size sensor including a magnet operably coupled to the syringe clamp, and a sensing member supported by the housing and configured to generate an output indicative of a magnetic field associated with the magnet; and software installed on the pump and programmed to use the output to determine a size of the syringe barrel received by the compartment.


Patent
Baxter International and Baxter Healthcare Sa | Date: 2016-11-17

A dialysis system includes a dialysis machine including at least one dialysis fluid pump and a logic implementer configured to (i) receive a plurality of predetermined therapy prescriptions that have been approved remote from the dialysis machine by a doctor/clinician for a particular patient, at least two of the plurality of predetermined therapy prescriptions having different treatment durations, different dialysis fluids or different ultrafiltration removal amounts, (ii) store the plurality of predetermined therapy prescriptions for use in operating the dialysis machine, (iii) cause the stored therapy prescriptions to be presented, (iv) allow a selection of one or more of the presented therapy prescriptions for one or more upcoming treatment, and (v) operate the at least one dialysis fluid pump according to the selected one or more therapy prescriptions.


Patent
Baxter International, Baxter Healthcare SA and Dyax | Date: 2017-01-18

The present application relates to monoclonal antibodies and antigen-binding portions thereof that specifically bind to the C-terminal or the center region of macrophage migration inhibitory factor (MIF). These anti-MIF antibodies and antigen-binding portions thereof further inhibit human MIF biological function.


Patent
Kewpie Kabushiki Kaisha also Trading As Kewpie Corporation and Baxter International | Date: 2017-02-08

An injection bag is formed of a laminate film, and includes an intermediate layer that includes a mixture of 60 to 90 mass% of a crystalline polyamide resin and 10 to 40 mass% of a noncrystalline polyamide resin. The crystalline polyamide resin has a combined content of a monomer and a low-molecular-weight polymer of 0.8 mass% or less. The noncrystalline polyamide resin includes a semi-aromatic polyamide.


Patent
Baxter International and Baxter Healthcare SA | Date: 2017-02-01

A dialysis system having multi-heater power coordination is described. In one embodiment, the system (10a, 10b) comprises: a first fluid heater; a second fluid heater; and a logic implementer (32, 50) configured to synchronize the duty cycles of the first and second heaters so that the first and second heaters are powered simultaneously as little as possible if a collective duty cycle of the first and second heaters is greater than one hundred percent. In another embodiment, the dialysis system (10a, 10b) comprises: a first fluid heater; a second fluid heater; a supplemental power source (14); and a logic implementer (32, 50) configured to use the supplemental power source such that when the first and second heaters are powered simultaneously, a collective current draw does not exceed a maximum allowable current draw of a branch power source (12) powering the system.

Loading Baxter International collaborators
Loading Baxter International collaborators